{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:36:05Z","timestamp":1760729765625},"reference-count":22,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1016\/j.jns.2005.07.021","type":"journal-article","created":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T19:41:59Z","timestamp":1149190919000},"page":"177-181","source":"Crossref","is-referenced-by-count":32,"title":["Anticholinesterasics in the treatment of cognitive impairment in multiple sclerosis"],"prefix":"10.1016","volume":"245","author":[{"given":"J.","family":"Porcel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Montalban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2005.07.021_bib1","series-title":"Handbook of multiple sclerosis","first-page":"33","article-title":"Cognitive impairment in multiple sclerosis","author":"Fisher","year":"2001"},{"key":"10.1016\/j.jns.2005.07.021_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/00019052-200306000-00006","article-title":"Cognitive dysfunction in multiple sclerosis. A review of recent developments","volume":"16","author":"Bobholz","year":"2003","journal-title":"Curr Opinion Neurol"},{"key":"10.1016\/j.jns.2005.07.021_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1212\/WNL.41.5.685","article-title":"Cognitive dysfunction in multiple sclerosis: I. Frequency, patterns, and prediction","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.07.021_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.41.5.692","article-title":"Cognitive dysfunction in multiple sclerosis: II. Impact on employment and social functioning","volume":"41","author":"Rao","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.07.021_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/00002512-199813050-00005","article-title":"Rivastigmine. A review of its use in Alzheimer's disease","volume":"13","author":"Spencer","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jns.2005.07.021_bib6","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2005.07.021_bib7","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s007020100008","article-title":"The beneficial effect of cholinesterase inhibitors on patients suffering from Parkinson's disease and dementia","volume":"108","author":"Werber","year":"2001","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2005.07.021_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1468-1331.2000.00046.x","article-title":"An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors","volume":"7","author":"Kumar","year":"2000","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jns.2005.07.021_bib9","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/apmr.2001.23833","article-title":"Open-label study of donepezil in traumatic brain injury","volume":"82","author":"Masanic","year":"2001","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jns.2005.07.021_bib10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/jnnp.54.2.110","article-title":"SPECT, MRI and cognitive functions in multiple sclerosis","volume":"54","author":"Pozzilli","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jns.2005.07.021_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/nimg.1996.0032","article-title":"Functional basis of memory impairment in multiple sclerosis: a [18F]FDG PET study","volume":"4","author":"Paulesu","year":"1996","journal-title":"Neuroimage"},{"key":"10.1016\/j.jns.2005.07.021_bib12","first-page":"123","article-title":"Effects of intravenous physostigmine and lecithin on memory loss in multiple sclerosis: report of a pilot study","volume":"2","author":"Leo","year":"1988","journal-title":"J Neurol Rehab"},{"key":"10.1016\/j.jns.2005.07.021_bib13","first-page":"74","article-title":"Oral physostigmine in the treatment of memory loss in multiple sclerosis (MS)","volume":"131","author":"Unverzagt","year":"1991","journal-title":"J Clin Exp Neuropsychol"},{"key":"10.1016\/j.jns.2005.07.021_bib14","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1093\/brain\/awg284","article-title":"Potentially adaptive functional changes in cognitive processing for patients with multiple sclerosis and their acute modulation by rivastigmine","volume":"126","author":"Parry","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jns.2005.07.021_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00004714-200006000-00010","article-title":"A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments","volume":"20","author":"Greene","year":"2000","journal-title":"J Clin Psychopharmacol"},{"issue":"Suppl. 3","key":"10.1016\/j.jns.2005.07.021_bib16","first-page":"A99","article-title":"Effects of donepezil on cognitive function in patients with multiple sclerosis","volume":"56","author":"Rorie","year":"2001","journal-title":"Neurology"},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2005.07.021_bib17","first-page":"S150","article-title":"Donepezile and cognitive impairment in multiple sclerosis: a double-blind pilot study","volume":"10","author":"Bosc\u00e0","year":"2004","journal-title":"Mult Scler"},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2005.07.021_bib18","first-page":"S150","article-title":"Effects of donepezil in multiple sclerosis: a single-centre trial","volume":"10","author":"Decoo","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2005.07.021_bib19","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1212\/01.WNL.0000142989.09633.5A","article-title":"Donepezil improved memory in multiple sclerosis in a randomized clinical trial","volume":"63","author":"Krupp","year":"2004","journal-title":"Neurology"},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2005.07.021_bib20","first-page":"S26003","article-title":"Relation to cognitive dysfunction to multiple neuroimaging measures over 24\u00a0weeks","volume":"64","author":"Christodoulou","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2005.07.021_bib21","first-page":"S143","article-title":"Design of a clinical trial to study the efficacy and safety of Exelon\u00ae (rivastigmine) in multiple sclerosis patients with cognitive disorders","volume":"9","author":"Porcel","year":"2003","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2005.07.021_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/brcg.1996.0044","article-title":"White matter disease and dementia","volume":"31","author":"Rao","year":"1996","journal-title":"Brain Cogn"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06001237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X06001237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T07:27:08Z","timestamp":1547623628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X06001237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":22,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0022510X06001237"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2005.07.021","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}